An infectious disease expert explains the results from Moderna’s latest vaccine trials

Biotech company Moderna, one of many organizations developing a vaccine for COVID-19, published results from an early-stage test of its experimental mRNA vaccine in the New England Journal of Medicine July 14. Vanderbilt University Medical Center staff scientist and protein chemistry expert Sanjay Mishra explains what the results of the phase 1 trial mean. What was Moderna testing for?…

Angola: IFAD Releases 26 Million Euros for Angola

Rome — Angola and the International Fund for Agricultural Development (IFAD) signed Wednesday a 26.2 million Euros financing agreement in Rome (Italy) to implement the project to improve the resilience projects of small producers. The agreement signed by the Angola’s permanent representative to the United Nations in Rome (Italy), Fátima Jardim, and IFAD president Gilbert…

COVID-19 Vaccine: Russia’s big Plan for Coronavirus Durg! Will Russia be the first country to produce the World’s first Experimental COVID-19 vaccine in August?

The head of Russia’s sovereign Wealth Fund announced that Russia plans to supply 30 million doses of the experimental coronavirus vaccine domestically this year, with the possibility of producing 170 million overseas. The total number of coronavirus cases in Russia has exceeded 7,50,000, making it the fourth-largest affected country in the world. The authorities had previously reported 6,428 new cases in the…